A week after Beau Friesen’s birth, his parents sensed something was amiss, a mystery that remains unsolved two years later. The Grunthal, Manitoba couple is on a quest for answers, heading to Florida. Beau, as an infant, experienced vomiting and a swollen stomach. Concerned first-time parents Tanner and Jordana Friesen consulted their family doctor in Steinbach, who referred them to the Children’s Hospital in Winnipeg after an X-ray revealed worrisome symptoms.
The Friesens embarked on a series of visits to specialists in gastroenterology, orthopedics, neurology, and genetics, driving up to five times a week from Grunthal to Winnipeg. Despite these efforts, the cause of Beau’s escalating symptoms remained elusive. Beau, now two, faces challenges such as reduced muscle tone, delayed crawling and walking, fatigue, digestion issues, and developmental delays affecting his motor skills and speech.
Their genetic counselor in Winnipeg suggested consulting Dr. Parul Jayakar, a leading figure in genetics and the head of clinical genetics at the Undiagnosed Disease Clinic in Nicklaus Children’s Hospital, Florida. The Friesens are hopeful that through genome sequencing, Jayakar can provide the long-awaited answers essential for Beau’s care and potentially aiding scientific research.
Securing a diagnosis would not only facilitate access to support programs but also offer a sense of community for the Friesens. Despite the support from loved ones and advocates, the journey to uncover Beau’s medical condition remains isolating for Jordana.
Dr. Jayakar, who pursued her master’s degree in Manitoba and later specialized in genetics in Florida, emphasizes the importance of genetic testing in diagnosing rare conditions. The clinic analyzes patients’ genes to identify variants that may explain their symptoms, paving the way for tailored treatment plans, including potential genetic therapy.
While genome sequencing is not currently available in Manitoba, the Friesens are covering the expenses for consultations, travel, and accommodation, with the clinic covering the sequencing costs. Manitoba Health does not fund the trip, prompting the Friesens to initiate a fundraising campaign to offset the expenses.
Dr. Patrick Frosk, Manitoba’s genetics lead, highlights the province’s use of exome monogenic sequencing for genetic testing but acknowledges the growing relevance of full genome sequencing. He underscores the evolving nature of genetic testing and its pivotal role in early diagnosis and treatment.
Despite the uncertainties surrounding Beau’s condition, the Friesens remain optimistic about finding answers that could potentially transform their son’s future. As they navigate this challenging journey, Beau’s resilience and infectious smile serve as a beacon of hope for his family.